[go: up one dir, main page]

SMP200800029B - 2-ammino-7,8-diidro-6h-pirido[4,3-d]pirimidin-5-oni - Google Patents

2-ammino-7,8-diidro-6h-pirido[4,3-d]pirimidin-5-oni

Info

Publication number
SMP200800029B
SMP200800029B SM200800029T SM200800029T SMP200800029B SM P200800029 B SMP200800029 B SM P200800029B SM 200800029 T SM200800029 T SM 200800029T SM 200800029 T SM200800029 T SM 200800029T SM P200800029 B SMP200800029 B SM P200800029B
Authority
SM
San Marino
Prior art keywords
pyrido
pyrimidin
dihydro
ones
amino
Prior art date
Application number
SM200800029T
Other languages
English (en)
Other versions
SMAP200800029A (it
Inventor
Timothy Machajewski
Cynthia M Shafer
Christopher Mcbride
Antonios-Mccrea
Brandon M Doughan
Barry H Levine
Yi Xia
Maureen Mckenna
X Michael Wang
Kris Mendehall
Yasheen Zhou
Baoqing Gong
Dan Gu
John Dolan
Paul A Renhowe
John Tulinsky
Kristin Brinner
Zhenhai Gao
Daniel Poon
Paul A Barsanti
Xiaodong Lin
Abran Costales
Alice Rico
Nathan Brammeier
Teresa Pick
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of SMAP200800029A publication Critical patent/SMAP200800029A/it
Publication of SMP200800029B publication Critical patent/SMP200800029B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/86—Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
SM200800029T 2005-09-30 2006-09-28 2-ammino-7,8-diidro-6h-pirido[4,3-d]pirimidin-5-oni SMP200800029B (it)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US72279605P 2005-09-30 2005-09-30
US83688606P 2006-08-09 2006-08-09
PCT/US2006/038181 WO2007041362A1 (en) 2005-09-30 2006-09-28 2-amino-7,8-dihydro-6h-pyrido[4,3-d] pyrimidin-5-ones

Publications (2)

Publication Number Publication Date
SMAP200800029A SMAP200800029A (it) 2008-05-07
SMP200800029B true SMP200800029B (it) 2008-05-07

Family

ID=37661234

Family Applications (1)

Application Number Title Priority Date Filing Date
SM200800029T SMP200800029B (it) 2005-09-30 2006-09-28 2-ammino-7,8-diidro-6h-pirido[4,3-d]pirimidin-5-oni

Country Status (31)

Country Link
US (2) US7671059B2 (it)
EP (1) EP1928875B1 (it)
JP (2) JP5036002B2 (it)
KR (1) KR101311757B1 (it)
AR (1) AR058072A1 (it)
AT (1) ATE514694T1 (it)
AU (1) AU2006297124B2 (it)
BR (1) BRPI0616701A2 (it)
CA (1) CA2624253C (it)
CR (1) CR9846A (it)
CY (1) CY1112028T1 (it)
DK (1) DK1928875T3 (it)
EA (1) EA016152B1 (it)
EC (1) ECSP088324A (it)
GE (1) GEP20115231B (it)
HR (1) HRP20110655T1 (it)
IL (1) IL190446A0 (it)
JO (1) JO2783B1 (it)
MA (1) MA29885B1 (it)
ME (1) ME01952B (it)
MY (1) MY143604A (it)
NO (1) NO342258B1 (it)
NZ (1) NZ566914A (it)
PE (1) PE20070621A1 (it)
PL (1) PL1928875T3 (it)
PT (1) PT1928875E (it)
RS (1) RS51795B (it)
SM (1) SMP200800029B (it)
TN (1) TNSN08143A1 (it)
TW (1) TWI373471B (it)
WO (1) WO2007041362A1 (it)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CL2007002994A1 (es) * 2006-10-19 2008-02-08 Wyeth Corp Compuestos derivados heterociclicos que contienen sulfamoilo, inhibidores de hsp90; composicion farmaceutica; y uso para el tratamiento del cancer, tal como cancer de mama, de colon y prostata, entre otros.
CN101225083A (zh) * 2007-01-16 2008-07-23 北京摩力克科技有限公司 四氢喹唑啉酮类化合物及其用于制备治疗和预防病毒性疾病的药物的用途
GB2449293A (en) * 2007-05-17 2008-11-19 Evotec Compounds having Hsp90 inhibitory activity
WO2009097578A1 (en) * 2008-02-01 2009-08-06 Takeda Pharmaceutical Company Limited Oxim derivatives as hsp90 inhibitors
EP2334379A2 (en) * 2008-09-26 2011-06-22 INSERM (Institut National de la Santé et de la Recherche Médicale) Host cell kinases as targets for antiviral therapies against hcv infection
WO2010060940A2 (en) * 2008-11-28 2010-06-03 Novartis Ag Hsp90 inhibitors for therapeutic treatment
PT2370076T (pt) * 2008-11-28 2017-03-31 Novartis Ag Combinações de inibidor hsp90
AU2009319050B2 (en) * 2008-11-28 2014-01-30 Novartis Ag Pharmaceutical combinations comprising a pyrido [4, 3-d] pyrimidine derived Hsp90-inhibitor and a HER2 inhibitor
AR075180A1 (es) * 2009-01-29 2011-03-16 Novartis Ag Formulaciones orales solidas de una pirido-pirimidinona
AR077405A1 (es) 2009-07-10 2011-08-24 Sanofi Aventis Derivados del indol inhibidores de hsp90, composiciones que los contienen y utilizacion de los mismos para el tratamiento del cancer
FR2949467B1 (fr) 2009-09-03 2011-11-25 Sanofi Aventis Nouveaux derives de 5,6,7,8-tetrahydroindolizine inhibiteurs d'hsp90, compositions les contenant et utilisation
US8404677B2 (en) * 2009-10-29 2013-03-26 Genosco Kinase inhibitors
WO2012104823A2 (en) 2011-02-04 2012-08-09 Novartis Ag Pyridopyrimidinone compounds in the treatment of neurodegenerative diseases
MX2014004559A (es) 2011-10-14 2014-08-01 Novartis Ag Derivados de 2-carboxamida cicloamino urea en combinacion con inhibidores de hsp90 para el tratamiento de enfermedades proliferativas.
ITTO20111013A1 (it) 2011-11-03 2013-05-04 Dac Srl Composti farmaceutici
CN103664938A (zh) * 2012-09-12 2014-03-26 山东亨利医药科技有限责任公司 含有嘧啶并环的syk抑制剂
RU2015121424A (ru) 2012-11-07 2016-12-27 Новартис Аг Комбинированная терапия
US9677907B2 (en) * 2013-03-14 2017-06-13 Itron Inc Intelligent receptacle
GB201306610D0 (en) * 2013-04-11 2013-05-29 Almac Discovery Ltd Pharmaceutical compounds
PT3053578T (pt) 2013-09-30 2021-02-09 Taiho Pharmaceutical Co Ltd Terapêutica de combinação de cancro usando composto de azabiciclo
US9944641B2 (en) * 2014-09-02 2018-04-17 Pierre Fabre Medicament Isoquinolinone derivatives useful in the treatment of cancer
KR20160035411A (ko) * 2014-09-23 2016-03-31 주식회사 오스코텍 LRRK2 (Leucine Rich Repeat Kinase 2) 키나제 억제제로서의 피리도피리미딘 유도체 화합물
KR101653560B1 (ko) * 2016-02-02 2016-09-12 한국화학연구원 신규한 화합물 또는 이의 약학적으로 허용가능한 염, 및 이를 유효성분으로 함유하는 인플루엔자 바이러스 감염으로 인한 질환의 예방 또는 치료용 약학적 조성물
RU2629599C1 (ru) * 2016-09-28 2017-08-30 Государственное бюджетное учреждение здравоохранения Московской области "Московский областной научно-исследовательский клинический институт им. М.Ф. Владимирского" (ГБУЗ МО МОНИКИ им. М.Ф. Владимирского) Способ химиолучевого лечения опухолей прямой кишки и анального канала
EP3636656A4 (en) 2017-06-09 2021-04-14 Chugai Seiyaku Kabushiki Kaisha METHOD OF SYNTHESIS OF PEPTIDE WITH N-SUBSTITUTED AMINO ACID
CN115916752B (zh) * 2020-06-26 2025-05-06 日本农药株式会社 芳基四氢吡啶衍生物或其盐类、和含有该化合物的杀虫剂及其使用方法
KR102912922B1 (ko) * 2021-03-08 2026-01-15 지난 유니버시티 피리도피리미딘계 화합물 및 이의 응용

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6165873A (ja) * 1984-09-07 1986-04-04 Mitsui Petrochem Ind Ltd ２−ピペラジノピリミジン誘導体
US4734418A (en) 1984-12-14 1988-03-29 Mitsui Petrochemical Industries, Ltd. Quinazoline compounds and antihypertensives
IL85347A0 (en) * 1987-02-11 1988-07-31 May & Baker Ltd Cyclic diones
CN100376571C (zh) * 2001-02-12 2008-03-26 霍夫曼-拉罗奇有限公司 6-取代的吡啶并嘧啶类化合物
DE102004018198A1 (de) * 2004-04-15 2005-11-03 Merck Patent Gmbh Sulfonamide
EP1838296B1 (en) 2004-10-20 2012-08-08 Resverlogix Corp. Flavanoids and isoflavanoids for the prevention and treatment of cardiovascular diseases
US20100152206A1 (en) * 2005-01-07 2010-06-17 Ralph Mazitschek Bicyclic Dihydropyrimidines and Uses Thereof
AU2006236557A1 (en) 2005-04-14 2006-10-26 Novartis Vaccines And Diagnostics Inc. 2-amino-quinazolin-5-ones as HSP90 inhibitors useful in treating proliferation diseases

Also Published As

Publication number Publication date
GEP20115231B (en) 2011-06-10
EA200800992A1 (ru) 2008-10-30
JO2783B1 (en) 2014-03-15
PE20070621A1 (es) 2007-09-06
SMAP200800029A (it) 2008-05-07
AU2006297124A1 (en) 2007-04-12
CR9846A (es) 2008-08-01
WO2007041362A1 (en) 2007-04-12
PT1928875E (pt) 2011-09-06
EP1928875A1 (en) 2008-06-11
EP1928875B1 (en) 2011-06-29
CA2624253C (en) 2015-06-16
ME01952B (en) 2011-12-31
PL1928875T3 (pl) 2011-11-30
JP2009510108A (ja) 2009-03-12
AU2006297124B2 (en) 2011-12-08
IL190446A0 (en) 2008-11-03
DK1928875T3 (da) 2011-10-03
CA2624253A1 (en) 2007-04-12
JP5036002B2 (ja) 2012-09-26
EA016152B1 (ru) 2012-02-28
NZ566914A (en) 2011-09-30
TW200728304A (en) 2007-08-01
ATE514694T1 (de) 2011-07-15
US7671059B2 (en) 2010-03-02
NO20082069L (no) 2008-06-09
KR101311757B1 (ko) 2013-09-26
JP2012158611A (ja) 2012-08-23
MY143604A (en) 2011-06-15
RS51795B (sr) 2011-12-31
HK1118823A1 (en) 2009-02-20
HRP20110655T1 (hr) 2011-10-31
TWI373471B (en) 2012-10-01
ECSP088324A (es) 2008-04-28
TNSN08143A1 (en) 2009-07-14
NO342258B1 (no) 2018-04-30
BRPI0616701A2 (pt) 2011-06-28
MA29885B1 (fr) 2008-10-03
AR058072A1 (es) 2008-01-23
US20100004237A1 (en) 2010-01-07
KR20080057318A (ko) 2008-06-24
US20070123546A1 (en) 2007-05-31
CY1112028T1 (el) 2015-11-04

Similar Documents

Publication Publication Date Title
SMP200800029B (it) 2-ammino-7,8-diidro-6h-pirido[4,3-d]pirimidin-5-oni
DOP2007000080A (es) Piridin [3,4-b] pirazinonas
DK1797099T3 (da) Piperidinylamino-thieno[2,3-D]pyrimidinforbindelser
HUS1900034I1 (hu) 6,7-telítetlen-7-karbamoil-szubsztituált morfinán-származékok
NL2000323A1 (nl) Pyrimidine-derivaten.
DK2194043T3 (da) Fremgangsmåder
MA28824B1 (fr) Derives de pyrimidine
NL1031741A1 (nl) Purinederivaten.
NL1029016A1 (nl) Tetrahydronafthyridinederivaten.
EP1917072A4 (en) VITAMIN FORMULATION
MA28813B1 (fr) Derives de pyrimidine
DK1963369T3 (da) Il-21-antagonister
ATE415400T1 (de) Pyrazolopyridinderivate
DE502005010218D1 (de) Spiralbohrer
MA28686B1 (fr) Derives de pyrrolopyridine
ZA200803658B (en) 2-amino-7,8-dihydro-6H-pyrido[4,3-d] pyrimidin-5-ones
DE112005003586A5 (de) Bohrfutter
ATE487718T1 (de) Substituierte bizyklische pyrimidonderivate
DE602006010581D1 (de) 4-phenyl-6-substituierte pyrimidin-2-carbonitrilderivate
ATE485294T1 (de) Azaindol-2-carboxamid-derivate
ATE527255T1 (de) Aryl-isoxazol-4-yl-imidazol-derivate
NL2000336A1 (nl) Spirocyclische derivaten.
DK1971588T3 (da) Tiglien-3-onderivater
DE602006014973D1 (de) Neuartige cercosporamidderivate
EP1847546A4 (en) imidazopyridine derivative